Linda C. Niessen

Vigilant Biosciences, Inc. engages in the innovation and development of solutions that aid in the early detection and intervention of cancer. It offers an oral cancer screening kit that include point-of-care product. The firm's products include OncAlert Oral Cancer RAPID Test and OncAlert Oral Cancer LAB Test. The company was founded by Matthew H. J. Kim and Elizabeth Franzmann in 2011 and is headquartered in Fort Lauderdale, FL.

DENTSPLY International, Inc. engages in the manufacturing and distributing of dental and other healthcare products. It designs, develops, manufactures and markets a full range of professional dental products, including dental implants, endodontic instruments and materials, orthodontic appliances, restorative materials, preventive materials and devices and prosthetic materials and devices. The company operates through the following segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses; Healthcare and Emerging Markets Businesses. The Dental Consumable and Certain International Business segment designs and manufactures company's chairside consumable products. The Certain Global Distribution Business segment designs, manufactures, sells and distributes dental specialty products, including endodontic, orthodontic and implant products, in most regions of the world. The Healthcare and Emerging Markets Businesse segment designs, manufactures, sales and distributes healthcare products, primarily urological and surgery-related products, throughout most of the world. DENTSPLY International was founded by Jacob F. Frantz, Dean C. Osborne, George H. Whiteley and John R. Sheppard on June 23, 1899 and is headquartered in York, PA.